Structural requirements of adenovirus VAI RNA for its translation enhancement function.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMC 366693)

Published in Mol Cell Biol on January 01, 1985

Authors

R A Bhat, P H Domer, B Thimmappaya

Articles citing this

Posttranscriptional regulation of hsp70 expression in human cells: effects of heat shock, inhibition of protein synthesis, and adenovirus infection on translation and mRNA stability. Mol Cell Biol (1987) 2.77

Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J Virol (1988) 2.37

Adenovirus VAI RNA complexes with the 68 000 Mr protein kinase to regulate its autophosphorylation and activity. EMBO J (1987) 2.17

E1a transactivation of the human HSP70 promoter is mediated through the basal transcriptional complex. Mol Cell Biol (1989) 1.83

Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus. J Virol (1985) 1.79

Effects of mutations in stem and loop regions on the structure and function of adenovirus VA RNAI. EMBO J (1988) 1.58

Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production. J Virol (2006) 1.53

Activities of adenovirus virus-associated RNAs: purification and characterization of RNA binding proteins. Proc Natl Acad Sci U S A (1998) 1.48

Functional dissection of adenovirus VAI RNA. J Virol (1989) 1.26

Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach. J Virol (1996) 1.25

In vitro analysis of virus-associated RNA I (VAI RNA): inhibition of the double-stranded RNA-activated protein kinase PKR by VAI RNA mutants correlates with the in vivo phenotype and the structural integrity of the central domain. J Virol (1994) 1.22

Multiple proteins bind to VA RNA genes of adenovirus type 2. Mol Cell Biol (1987) 1.21

Comparative analysis of the structure and function of adenovirus virus-associated RNAs. J Virol (1993) 1.19

Binding of the adenovirus VAI RNA to the interferon-induced 68-kDa protein kinase correlates with function. Proc Natl Acad Sci U S A (1991) 1.13

RNA binding and intramolecular interactions modulate the regulation of gene expression by nuclear factor 110. RNA (2003) 0.99

Effect of single-base substitutions in the central domain of virus-associated RNA I on its function. J Virol (1995) 0.96

Suppression of the translation defect phenotype specific for a virus-associated RNA-deficient adenovirus mutant in monkey cells by simian virus 40. J Virol (1986) 0.92

VA RNAs from avian and human adenoviruses: dramatic differences in length, sequence, and gene location. J Virol (1986) 0.90

Characterization of a low-molecular-weight virus-associated (VA) RNA encoded by simian adenovirus type 7 which functionally can substitute for adenovirus type 5 VA RNAI. J Virol (1986) 0.88

Efficient production of adenovirus vector lacking genes of virus-associated RNAs that disturb cellular RNAi machinery. Sci Rep (2013) 0.83

Efficient expression of small RNA polymerase III genes from a novel simian virus 40 vector and their effect on viral gene expression. Nucleic Acids Res (1989) 0.81

Persistently adenovirus-infected lymphoid cells express microRNAs derived from the viral VAI and especially VAII RNA. Virology (2013) 0.81

Articles cited by this

Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68

Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res (1981) 61.59

Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol (1977) 41.93

Faithful transcription of eukaryotic genes by RNA polymerase III in systems reconstituted with purified DNA templates. J Biol Chem (1979) 11.68

Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1981) 7.43

Nucleotide sequences in Xenopus 5S DNA required for transcription termination. Cell (1981) 7.03

Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science (1981) 6.34

Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell (1982) 5.80

Transcriptional control regions of the adenovirus VAI RNA gene. Cell (1980) 5.64

Purified lupus antigen La recognizes an oligouridylate stretch common to the 3' termini of RNA polymerase III transcripts. Cell (1984) 4.64

Structure of genes for virus-associated RNAI and RNAII of adenovirus type 2. Proc Natl Acad Sci U S A (1980) 3.45

Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection. Proc Natl Acad Sci U S A (1984) 3.11

RNA of low molecular weight in KB cells infected with adenovirus type 2. J Mol Biol (1966) 3.09

A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2. Cell (1976) 3.00

Role of DNA-dependent RNA polymerases II and III in transcription of the adenovirus genome late in productive infection. Proc Natl Acad Sci U S A (1974) 2.95

Interaction between VA RNA and the lupus antigen La: formation of a ribonucleoprotein particle in vitro. Proc Natl Acad Sci U S A (1982) 2.83

Adenovirus VAI RNA facilitates the initiation of translation in virus-infected cells. Cell (1984) 2.76

Control region for adenovirus VA RNA transcription. Proc Natl Acad Sci U S A (1981) 2.56

Low molecular weight viral RNAs transcribed by RNA polymerase III during adenovirus 2 infection. Cell (1976) 2.33

Binding of adenovirus VA RNA to mRNA: a possible role in splicing? Nature (1980) 2.28

Segment-directed mutagenesis: construction in vitro of point mutations limited to a small predetermined region of a circular DNA molecule. Proc Natl Acad Sci U S A (1980) 2.10

Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virus-associated RNAs in the lytic growth of adenovirus 5. Proc Natl Acad Sci U S A (1983) 2.06

Translational control of SV40 T antigen expressed from the adenovirus late promoter. Cell (1983) 1.90

The nucleotide sequence of a low molecular weight ribonucleic acid from cells infected with adenovirus 2. J Biol Chem (1971) 1.89

A mutation which alters initiation of transcription by RNA polymerase III on the Ad5 chromosome. Cell (1979) 1.75

Studies of low molecular weight RNA from cells infected with adenovirus 2. I. The sequences at the 3' end of VA-RNA I. J Biol Chem (1977) 1.58

Adenovirus mutants with DNA sequence perturbations in the intragenic promoter of VAI RNA gene allow the enhanced transcription of VAII RNA gene in HeLa cells. Nucleic Acids Res (1984) 1.43

The conformation of adenovirus VAI-RNA in solution. Nucleic Acids Res (1981) 1.37

Expression of dihydrofolate reductase, and of the adjacent EIb region, in an Ad5-dihydrofolate reductase recombinant virus. Nucleic Acids Res (1984) 1.32

Organization of the noncontiguous promoter components of adenovirus VAI RNA gene is strikingly similar to that of eucaryotic tRNA genes. Mol Cell Biol (1983) 1.14

Articles by these authors

The genome of simian virus 40. Science (1978) 24.46

Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell (1982) 5.80

Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell (1986) 4.72

A cellular protein, activating transcription factor, activates transcription of multiple E1A-inducible adenovirus early promoters. Proc Natl Acad Sci U S A (1987) 3.91

Adenovirus EIIA early promoter: transcriptional control elements and induction by the viral pre-early EIA gene, which appears to be sequence independent. Proc Natl Acad Sci U S A (1985) 3.32

Identification of a factor in HeLa cells specific for an upstream transcriptional control sequence of an EIA-inducible adenovirus promoter and its relative abundance in infected and uninfected cells. Proc Natl Acad Sci U S A (1986) 2.81

Nucleotide sequence analysis of viable deletion mutants lacking segments of the simian virus 40 genome coding for small t antigen. J Virol (1979) 2.28

NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A. J Virol (1992) 2.10

The early region of SV40 DNA may have more than one gene. Cell (1977) 2.09

Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virus-associated RNAs in the lytic growth of adenovirus 5. Proc Natl Acad Sci U S A (1983) 2.06

Two promoter-specific host factors interact with adjacent sequences in an EIA-inducible adenovirus promoter. Proc Natl Acad Sci U S A (1987) 1.95

Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees. J Infect Dis (1989) 1.88

Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus. J Virol (1985) 1.79

A mutation which alters initiation of transcription by RNA polymerase III on the Ad5 chromosome. Cell (1979) 1.75

Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol (1997) 1.63

Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood (1993) 1.62

SV40 mutant tsA1499 is heat-sensitive for lytic growth but generates cold-sensitive rat-cell transformants. Cold Spring Harb Symp Quant Biol (1980) 1.52

Complementation of adenovirus virus-associated RNA I gene deletion by expression of a mutant eukaryotic translation initiation factor. Proc Natl Acad Sci U S A (1989) 1.51

Adenovirus mutants with DNA sequence perturbations in the intragenic promoter of VAI RNA gene allow the enhanced transcription of VAII RNA gene in HeLa cells. Nucleic Acids Res (1984) 1.43

MLL fusion partners AF4 and AF9 interact at subnuclear foci. Leukemia (2004) 1.42

A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease. J Med Virol (1990) 1.27

Functional dissection of adenovirus VAI RNA. J Virol (1989) 1.26

Unique presence of 2-methylthio-ribosylzeatin in the transfer ribonucleic acid of the bacterium Pseudomonas aeruginosa. Biochem Biophys Res Commun (1974) 1.20

The embryonal carcinoma stem cell Ela-like activity involves a differentiation-regulated transcription factor. Nucleic Acids Res (1990) 1.16

Yeast artificial chromosome cloning of a two-megabase-size contig within chromosomal band 18q21 establishes physical linkage between BCL2 and plasminogen activator inhibitor type-2. Genomics (1991) 1.15

Organization of the noncontiguous promoter components of adenovirus VAI RNA gene is strikingly similar to that of eucaryotic tRNA genes. Mol Cell Biol (1983) 1.14

Monoclonal antibodies detect monocyte/macrophage activation and differentiation antigens and identify functionally distinct subpopulations of human rheumatoid synovial tissue macrophages. Am J Pathol (1991) 1.11

Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes. J Clin Invest (1994) 1.10

Meiotic recombination between yeast artificial chromosomes yields a single clone containing the entire BCL2 protooncogene. Proc Natl Acad Sci U S A (1990) 1.08

Adenovirus vectors for gene expression. Curr Opin Biotechnol (1991) 0.98

The primary structure of regions of SV 40 DNA encoding the ends of mRNA. Prog Nucleic Acid Res Mol Biol (1976) 0.98

In vivo identification of multiple promoter domains of adenovirus EIIA-late promoter. EMBO J (1987) 0.95

The hepatitis C virus NS2 protein generated by NS2-3 autocleavage is required for NS5A phosphorylation. Biochem Biophys Res Commun (1999) 0.95

Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee. J Infect Dis (1992) 0.93

Suppression of the translation defect phenotype specific for a virus-associated RNA-deficient adenovirus mutant in monkey cells by simian virus 40. J Virol (1986) 0.92

Cloning and sequence analysis of four t(9;11) therapy-related leukemia breakpoints. Leukemia (1998) 0.92

Nucleotide sequence of the gene for the major structural protein of SV40 virus. Nucleic Acids Res (1977) 0.91

The chromosome 4q21 gene (AF-4/FEL) is widely expressed in normal tissues and shows breakpoint diversity in t(4;11)(q21;q23) acute leukemia. Blood (1993) 0.91

Cloning and developmental expression of the murine homolog of the acute leukemia proto-oncogene AF4. Oncogene (1997) 0.90

Nucleotide sequence of DNA template for the 3' ends of SV40 mRNA. II. The sequence of the DNA fragment EcorII-F and a part of EcorII-H. J Biol Chem (1978) 0.89

The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23)-containing acute lymphoblastic leukemia. Blood (1994) 0.89

Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing. J Biol Chem (1998) 0.88

Reactivity of human tissues with monoclonal antibodies to myeloid activation and differentiation antigens. An immunohistochemical study. Pathobiology (1990) 0.87

Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid. Vaccine (1999) 0.86

Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model. Vaccine (1994) 0.86

Selective and opposing actions of progesterone receptor isoforms in human endometrial stromal cells. Mol Cell Endocrinol (2006) 0.85

Nucleotide sequences of DNA encoding the 3' ends of SV40 mRNA. I. The sequence of the DNA fragment Hi-DII,III-G. J Biol Chem (1978) 0.83

Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junction. Virology (1994) 0.83

Correlation of the expression of double-stranded RNA-dependent protein kinase (p68) with differentiation in head and neck squamous cell carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 0.83

Efficient expression of small RNA polymerase III genes from a novel simian virus 40 vector and their effect on viral gene expression. Nucleic Acids Res (1989) 0.81

Guanine-rich (GGNNGG) elements at chromosomal breakpoints interact with a loop-forming, single-stranded DNA-binding protein. Oncogene (1994) 0.81

Results of treatment of distal extra: articular femur fractures with locking plates using minimally invasive approach--experience with 25 consecutive geriatric patients. Musculoskelet Surg (2014) 0.79

Expression of the protein kinase p-68 recognized by the monoclonal antibody TJ4C4 in human lung neoplasms. Virchows Arch B Cell Pathol Incl Mol Pathol (1992) 0.79

Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees. Vaccine (1997) 0.79

Functional properties of a conditionally phenotypic, estrogen-responsive, human osteoblast cell line. J Cell Biochem (1997) 0.79

Monoclonal antibodies defining shared human macrophage-endothelial antigens. Pathobiology (1992) 0.78

Immunohistochemical detection of double-stranded-RNA-dependent protein kinase (p68) with a novel monoclonal antibody TJ4C4. A case report of an AIDS-associated Kaposi's sarcoma treated with alpha-interferon. Tumour Biol (1992) 0.76

Isoaccepting lysine transfer ribonucleic acid species of Pseudomonas aeruginosa. Biochem J (1975) 0.75

Fatal thrombotic thrombocytopenic purpura despite plasmapheresis. A case report of autopsy findings. Haemostasis (1989) 0.75

Pseudo-Gaucher histiocytes identified up to 1 year after transplantation for CML are BCR/ABL-positive. Leukemia (1998) 0.75

Biology of hepatitis delta virus. Transfus Med Rev (1988) 0.75

The structure of genes, intergenic sequences, and mRNA from SV40 virus. Cold Spring Harb Symp Quant Biol (1978) 0.75